{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-017488","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2024-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.260382+00:00","generated_at":"2026-06-03T00:57:10.636366+00:00","sec_items":["3.01","3.03","5.03","5.08","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Mangoceuticals granted Nasdaq bid-price extension to Oct 24 and conditional equity compliance","bullets":["Received 180-day extension until Oct 24, 2024 to meet $1.00 minimum bid price requirement.","Nasdaq conditionally approved $2.5M stockholders' equity compliance based on April 25 8-K; must re-demonstrate in next periodic report.","Filed Certificate of Correction for Series C Preferred stock to fix cross-references, effective April 29, 2024.","2024 Annual Meeting set for June 17, 2024; stockholder proposals due May 13, 2024.","Shareholders authorized reverse stock split (1:2 to 1:50) at March 25 special meeting, may be used to regain bid price compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-017488","json":"https://secwatch.observer/filing/0001493152-24-017488.json","markdown":"https://secwatch.observer/filing/0001493152-24-017488.md","text":"https://secwatch.observer/filing/0001493152-24-017488.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000149315224017488/0001493152-24-017488-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000149315224017488/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T00:57:10.636366+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d5d2255244360d218591665f3890cf62089f4288","claim":"MANGOCEUTICALS, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"filed by the Company with the Commission on November 7, 2023, on November 3, 2023, the Company received a letter from Nasdaq notifying the Company that it was not in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) (the “ Rule ”), which requires companies listed on the Nasdaq Capital Market to maintain stockholders’ equity of at least $2,500,000. In the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, the Company reported stockholders’ equity of $1,354,821, which is","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1938046/000149315224017488/0001493152-24-017488-index.htm","confidence":0.7,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"},{"claim_id":"f29c5139a24b840dfa89de7cb5b19f692f81be7d","claim":"MANGOCEUTICALS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"October 30, 2023, the Company received written notice (the “ Notification Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that it was not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1938046/000149315224017488/0001493152-24-017488-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}